Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 20.63 | N/A |
| PEG Ratio (TTM) | -1.38 | N/A |
| P/S Ratio (TTM) | 4.85 | N/A |
| P/B Ratio (TTM) | 3.00 | N/A |
| P/FCF Ratio (TTM) | 14.60 | N/A |
| Price to 5YR AVG Earnings Ratio | 0.35 | N/A |
| Price to 5YR AVG FCF Ratio | 3.35 | N/A |
Profitability (75%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 11.70% | N/A |
| ROE (TTM) | 14.61% | N/A |
| Net Profit Margin (TTM) | 23.47% | N/A |
| ROIC 5YR AVG | 32.76% | N/A |
Growth (93%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 249.02% | 39.15% | 178.72% |
| Revenue | 5.03% | 49.90% | 46.93% |
| Net Income | 8.32% | 42.98% | 38.63% |
| Cash Flow | 1.74% | 116.82% | 102.94% |
Health (65%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 5.17 | N/A |
| Quick Ratio (TTM) | 5.15 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | 124.26 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 3.35 | N/A |
| LTL to 5YR AVG FCF | 0.17 | N/A |
| Shares Outstanding Growth 5YR AVG | -16.66% | N/A |